Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin

Citation
Avgerinos I, Liakos A, Tsapas A, Bekiari E. Diabetes Metab Syndr Obes 2019;12:2549–57.